Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study aims to improve drug dosing for sick kids

NCT ID NCT05055830

First seen Nov 01, 2025 · Last updated Jun 20, 2026 · Updated 34 times

Summary

This study looks at how certain drugs behave in the bodies of critically ill children under 21 in a heart intensive care unit. Researchers will collect leftover blood samples from routine care to measure drug levels. The goal is to better understand dosing and safety for drugs like methadone, caffeine, acetaminophen, and milrinone. No new drugs are given—just careful observation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHILDREN, ADULT are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Duke University Medical Center

    RECRUITING

    Durham, North Carolina, 27705, United States

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Methadone, Caffeine, Acetaminophen, Milrinone

What this could lead to

If successful, this could lead to safer, more effective dosing guidelines for commonly used drugs in critically ill children.

What could go wrong

This is an observational study, not a treatment trial. It may not produce clear dosing recommendations, and results may not apply to all children.

Conditions

The condition(s) this trial relates to.

Critical Illness heart disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.